CIK 0001711754 · Non-accelerated filer<br>Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 475205835
- Phone
- 8589643720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −15,975 | 0 | ||
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +15,975 | 15,975 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −19,025 | 0 | ||
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +19,025 | 19,025 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −35,000 | 0 | ||
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −35,000 | 0 | ||
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −32,500 | 0 | ||
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +32,500 | 32,500 | ||
| 2025-11-18 | Juda Scott Director | Returned to the company · Stock Option (right to buy) | −12,500 | 0 | ||
| 2025-11-18 | Juda Scott Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2025-11-18 | Ganjei James Kelly Director | Returned to the company · Stock Option (right to buy) | −108,000 | 0 | ||
| 2025-11-18 | Ganjei James Kelly Director | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2025-11-18 | Ganjei James Kelly Director | Returned to the company · Stock Option (right to buy) | −108,000 | 0 | ||
| 2025-11-18 | Ganjei James Kelly Director | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2025-11-18 | Ganjei James Kelly Director | Returned to the company · Stock Option (right to buy) | −15,975 | 0 | ||
| 2025-11-18 | Ganjei James Kelly Director | Grant or award · Stock Option (right to buy) | +15,975 | 15,975 | ||
| 2025-11-18 | Ganjei James Kelly Director | Returned to the company · Stock Option (right to buy) | −19,025 | 0 |
Page 4 of 11 · 216 trades